drugset / Trial / NCT00151489

Safety and Efficacy Study of Pregabalin in Fibromyalgia

NCT00151489

Phase 3 Completed 1020 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.

Timeline

Start
2005-04
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications